Friday 6 November 2026
Export VMD’s income statement to Excel — free account
Viemed Healthcare, Inc.
VMD Healthcare Medical Devices
Viemed Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $270.3 million, up 20.5% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +38.1%
- Free cash flow
- −67.6%
- Total debt
- −62.8%
Quarter to September 2026, against a year earlier
9.18
0.17
+1.89%
Follow VMD
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 5 | 8 |
| 10.79% | 10.54% | 10.08% | 10.87% | ||
| 7.94% | 7.93% | 7.46% | 7.62% | ||
ROIC |
8.83% | 10.19% | 10.66% | 10.62% | |
Return on Tangible Assets |
17.32% | 17.50% | 17.42% | 17.84% | |
Average Days of Receivables |
34.86 | 39.71 | 39.00 | 41.03 | |
Free Cash Flow per Share |
0.44 | 0.66 | 0.62 | 0.40 | |
Free Cash Flow |
17.25 | 25.52 | 23.60 | 15.23 | |
Capital Expenditures |
(16.22) | (13.18) | (18.74) | (20.23) | |
| Other line items | |||||
Cash ROIC |
10.04% | 15.49% | 14.42% | 8.98% | |
Accounts Receivable Turnover |
10.66 | 9.89 | 10.26 | 9.67 | |
Accounts Payable Turnover |
18.15 | 14.72 | 13.34 | 13.70 | |
Inventory Turnover |
24.52 | 25.08 | 26.75 | 26.92 | |
Average Days of Payables |
23.31 | 25.75 | 31.26 | 29.34 | |
Days of Inventory on Hand |
16.04 | 15.56 | 14.99 | 12.57 | |
Tax Rate |
(0.29) | (0.30) | (0.29) | (0.29) | |
Research and Development Expense of Revenue |
1.12% | 0.98% | 0.81% | 0.70% | |
Selling, General and Administrative Expense of Revenue |
48.28% | 47.81% | 48.08% | 47.98% | |
Share Based Compensation of Revenue |
2.53% | 2.43% | 2.21% | 2.24% | |
Interest Coverage |
17.31 | 18.10 | 17.05 | 23.33 | |
Operating CF/Net income |
2.24 | 2.60 | 2.92 | 2.27 | |
Depreciation/Fixed assets |
0.27 | 0.29 | 0.30 | 0.31 | |
Capex/Depreciation |
(0.77) | (0.59) | (0.82) | (0.88) | |
Revenue per Share |
6.95 | 7.46 | 7.89 | 8.15 | |
Operating CF per Share |
0.86 | 1.01 | 1.11 | 0.93 | |
Capex per Share |
(0.42) | (0.34) | (0.49) | (0.53) | |
Capex to Sales |
0.06 | 0.05 | 0.06 | 0.07 |
Columns are period end dates · fundamentals updated 6 Nov 2026